The role of cytokine gene polymorphisms in the pathogenesis of abdominal aortic aneurysms: A case-control study

Journal of Vascular Surgery

Volumn 37, Issue 5, 2003, Pages 999-1005

  Bown, M J ^a   Burton, P R ^a   Horsburgh, T ^a   Nicholson, M L ^a   Bell, P R F ^a   Sayers, R D ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ABDOMINAL AORTA ANEURYSM; ADULT; AGE; AGED; ALLELE; ARTICLE; CASE CONTROL STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE ASSOCIATION; DNA POLYMORPHISM; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; RISK FACTOR; SEX;

EID: 0038710720     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1067/mva.2003.174     Document Type: Article

References (35)

1. Summer DS, Hokanson DE, Strandness DE Jr. Stress-strain characteristics and collagen-elastin content of adominal aortic aneurysms. Surg Gynaecol Obstet 1970;130:459-66.
2. White JV, Haas K, Phillips S, et al. Adventitial elastolysis is a primary event in aneurysm formation. J Vasc Surg 1993;17:371-80.
3. Rizzo RJ, McCarthy WJ, Dixit SN, et al. Collagen types and matrix protein content in human abdominal aortic aneurysms. J Vasc Surg 1989;10:365-73.
4. Mesh CL, Baxter BT, Pearce WH, et al. Collagen and elastin gene expression in aortic aneurysms. Surgery 1992;112:256-61.
5. Elmore JR, Keister BF, Franklin DP, et al. Expression of matrix metalloproteinases and TIMPs in human abdominal aortic aneurysms. Ann Vasc Surg 1998;12:221-8.
6. Carrell TWG, Burnand KG, Wells GMA, et al. Stromelysin-1 (matrix metalloproteinase-3) and tissue inhibitor of metalloproteinase-3 are overexpressed in the wall of abdominal aortic aneurysms. Circulation 2002;105:477-82.
7. Newman KM, Jean-Claude J, Li H, et al. Cytokines that activate proteolysis are increased in abdominal aortic aneurysms. Circulation 1994;90:11224-7.
8. Shah PK. Inflammation, metaln-loproteinases, and increased proteolysis: An emerging paradigm in aortic aneurysm. Circulation 1997;96:2115-7.
9. Koch AE, Haines GK, Rizzo RJ, et al. Human abdominal aortic aneurysms: Immunophenotypic analysis suggesting an immune-mediated response. Am J Pathol 1990;137:1199-1213.
10. Ries C, Petrides PE. Cytokine regulation of matrix metalloproteinase activity and its regulatory/dysfunction in disease. Biol Chem Hoppe-Seyler 1995;376:345-55.
11. Alexander JP, Samples JR, Acott TS. Growth factor and cytokine modulation of trabecular meshwork matrix metalloproteinase and TIMP expression. Curr Eye Res 1998;17:276-85.
12. Tracey KJ, Cerami A. Tumour necrosis factor: A pleiotropic cytokine and therapeutic target. Annu Rev Med 1994;45:491-503.
13. Strieter RM, Kunkel SL. The immunopathology of chemotactic cytokines. In: Lindley IJ, editor. The Chemokines. New York: Plenum Press; 1993.
14. Bogdan C, Vodovotz Y, Nathan C. Macrophage deactivation by interleukin 10. J Exp Med 1991;174:1549-55.
15. Fiorentino DF, Zlotnik A, Viera P, et al. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol 1991;146:3444-51.
16. Human cytokine gene on-line database [accessed Apr 3, 2002]. Available from: http://bris.ac.uk/pathandmicro/services/GAI/cytokine4.htm
17. Turner DM, Williams DM, Sankaran D, et al. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 1997;24:1-8.
18. Eskdale J, Gallagher G, Verweij CL, et al. Interleukin 10 secretion in relation to human IL-10 locus haplotypes. Proc Natl Acad Sci U S A 1998;95:9465-70.
19. Fishman D, Faulds G, Jeffrey R, et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic onset juvenile chronic arthritis. J Clin Invest 1998;102:1369-76.
20. Wilson AG, Symons JA, McDowell TL, et al. Effects of a polymorphism in the human tumour necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci U S A 1997;94:3195-9.
21. Pociot F, Molvig J, Wogensen L, et al. A Taq1 polymorphism in the human interleukin-1 beta (IL-1beta) gene correlates with IL-1beta secretion in vitro. Eur J Clin Invest 1992;22:396-402.
22. Johansen K, Koepsell T. Familial tendency for abdominal aortic aneurysms. JAMA 1986;256:1934-6.
23. Webster MW, St Jean PL, Steed DL, et al. Abdominal aortic aneurysm: Results of a family study. J Vasc Surg 1991;13:366-72.
24. Smith FC, Grimshaw GM, Paterson IS, et al. Ultrasonographic screening for abdominal aortic aneurysm in the urban community. Br J Surg 1993;80:1406-9.
25. Lucarotti M, Shaw E, Poskitt K, et al. The Gloucestershire aneurysm screening programme: The first 2 years' experience. Eur J Vasc Surg 1993;7:397-401.
26. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acid Res 1988;16:1215.
27. Morse HR, Olomolaiye OO, Wood NAP, et al. Induced heteroduplex genotyping of TNF-α, IL-1β, IL-6 and IL-10 polymorphisms associated with transcriptional regulation. Cytokine 1999;11:789-95.
28. Silvestre JS, Mallat Z, Tamarat R, et al. Regulation of matrix metalloproteinase activity in ischaemic tissue by interleukin-10: Role in ischaemia-induced angiogenesis. Circ Res 2001;89:259-64.
29. Stearns ME, Rhim J, Wang M. Interleukin 10 (IL-10) inhibition of primary human prostate cell-induced angiogenesis: IL-10 stimulation of tissue inhibitor of mctalloproteinase-1 and inhibition of matrix metalloproteinase (MMP)-2/MMP-9 secretion. Clin Cancer Res 1999;5:189-96.
30. Wang M, Fudge K, Rhim JS, et al. Cytokine regulation of matrix metalloproteinases and their inhibitors in human papillomavirus-18 transformed human prostatic tumour cell lines. Oncol Res 1996;8:303-15.
31. Fang XM, Schroder S, Hoeft A, et al. Comparison of two polymorphisms of the interleukins-1 gene family: Interleukin-1 receptor antagonist polymorphism contributes to susceptibility to severe sepsis. Crit Care Med 1999;27:1330-4.
32. Jones KG, Brull DJ, Brown LC, et al. Interleukin-6 (IL-6) and the prognosis of abdominal aortic aneurysms. Circulation 2001;103:2260-5.
33. Breslow NE, Day NE. Statistical methods in cancer research. I: The analysis of case-control studies. IARC Scientific Publications No. 32. Lyon: IARC; 1987.
34. Boffetta P, Pearce N. Epidemiological studies on genetic polymorphism: Study design issues and measures of occurrence and association. In: Ryder W, editor: Metabolic polymorphsisms and susceptibility to cancer. IARC Sci Publ 1999;148:97-108.
35. Moore KW, de Waal Malefyt R, Coffman RL, et al. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001;19:683-765.